Ianthe Bryant

Oncogenic Activity of Epidermal Growth Factor Receptor Kinase Mutant Alleles Is Enhanced by the T790M Drug Resistance Mutation

Nadia Godin-Heymann, Ianthe Bryant, Miguel N. Rivera et al. · Cancer Research · 2007 · 151 citations · Full text

A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines

Eric E. Williams, Laurie J Trout, Richard L. Gallo et al. · Cancer Letters · 2003 · 48 citations

Medicine, Active Erbb4 Mutant, Anti-cancer Agent +7

Anilinodialkoxyquinazolines:  Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Potential Tumor Imaging Probes

Henry F. VanBrocklin, John K. C. Lim, Stephanie L. Coffing et al. · Journal of Medicinal Chemistry · 2005 · 32 citations · Full text

Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.

Desi J Penington, Ianthe Bryant, David J. Riese · PubMed · 2002 · 32 citations

Molecular Regulation, Active Erbb2 Mutant, Molecular Biology +19

Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines

Richard L. Gallo, Ianthe Bryant, Rachael Fry et al. · Biochemical and Biophysical Research Communications · 2006 · 27 citations · Full text

Signal Transduction, Signaling Pathway, Medicine +9